Indication
Community acquired bacterial pneumonia
Community-acquired bacterial pneumonia is an acute infection of the pulmonary parenchyma contracted outside of healthcare settings by bacterial pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, or atypical organisms. Read more about Community acquired bacterial pneumonia
9 drugs 4 manufacturers
Drugs that treat it
Common Community acquired bacterial pneumonia therapies.
BAXDELA (delafloxacin meglumine)
NUZYRA (omadacycline tosylate)
NUZYRA (omadacycline tosylate)
NUZYRA (omadacycline tosylate)
NUZYRA (omadacycline tosylate)
XENLETA (lefamulin acetate)
XENLETA (lefamulin acetate)
ZEVTERA (ceftobiprole medocaril)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCommunity-acquired bacterial pneumonia is an acute infection of the pulmonary parenchyma contracted outside of healthcare settings by bacterial pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, or atypical organisms.
It predominantly affects the lower respiratory tract across pediatric and adult populations, with the highest morbidity and mortality occurring among older adults and individuals with cardiopulmonary comorbidities or immunocompromise.
Pathophysiologically characterized by alveolar inflammation, exudative consolidation, and impaired gas exchange, the condition typically manifests clinically with fever, productive cough, pleuritic chest pain, dyspnea, and demonstrable new infiltrates on chest imaging.
- nih.gov
Community-acquired bacterial pneumonia is an acute infection of the pulmonary parenchyma contracted outside of healthcare settings by bacterial pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, or atypical organisms It predominantly affects the lower respiratory tract across pediatric and adult populations, with the highest morbidity and mortality occurring among older adults and individuals with cardiopulmonary comorbidities or immunocompromise
- merckmanuals.com
Community-acquired bacterial pneumonia is an acute infection of the pulmonary parenchyma contracted outside of healthcare settings by bacterial pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, or atypical organisms It predominantly affects the lower respiratory tract across pediatric and adult populations, with the highest morbidity and mortality occurring among older adults and individuals with cardiopulmonary comorbidities or immunocompromise Pathophysiologically charact...
- idsociety.org
Pathophysiologically characterized by alveolar inflammation, exudative consolidation, and impaired gas exchange, the condition typically manifests clinically with fever, productive cough, pleuritic chest pain, dyspnea, and demonstrable new infiltrates on chest imaging
Personalize your experience
Follow Community acquired bacterial pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.